BackZevra Therapeutics Overview

Zevra Therapeutics Current Assets

Zevra Therapeutics's current assets is $250M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$251.30M
11.03% YoYΔ $24.96M vs prior year quarter

Peer trimmed avg / median

Loading

Zevra Therapeutics Current Assets History

Loading

Zevra Therapeutics vs. peers: Current Assets Comparison

Loading

Zevra Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Zevra Therapeutics (ZVRA) FAQ

As of the most recent data (June 2026), ZVRA shows a current assets of $250M. That compares with $230M in the prior-year period — up 11.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ZVRA's current assets is now $250M (was $230M) — a 11.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Zevra Therapeutics is outperforming or lagging.

Tracking ZVRA's current assets over time shows whether Zevra Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $250M That compares with $230M in the prior-year period — up 11.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Zevra Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $250M) with ownership activity and broader fundamentals.

Zevra Therapeutics's current assets is $250M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.